Remyelination as a therapeutic target in the treatment of multiple sclerosis.

AIMS Neurosci · 2025 · PMC12782952 · PMID 41523329

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While numerical reductions in latency delay were observed with opicinumab, the differences did not reach statistical significance in either the PP or ITT populations [184] .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.